💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @Tickeron | 12 |
| @FlashAlert_me | 10 |
| @InsiderAlerts4U | 7 |
| @HealthcareBeat | 3 |
| @TheMarketsDaily | 2 |
Recent Tweets for MYGN
 |
@Tickeron $MYGN's price moved above its 50-day Moving Average on October 20, 2020. View odds for this and other indicators:… https://t.co/tlvC4Wx1Ep October 21st 2020, 10:10pm |
 |
@YuMiStockTrade https://t.co/v6MD2eZBM5 $MYGN Moving October 21st 2020, 8:10pm |
|
@Tickeron $MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/0uDQkjwWkh October 20th 2020, 8:10pm |
 |
@EnterpriseLeade Myriad Genetics $MYGN Cut to Sell at BidaskClub https://t.co/LNtg2d34zT October 20th 2020, 3:10am |
 |
@TheMarketsDaily Myriad Genetics $MYGN Cut to Sell at BidaskClub https://t.co/QWKKJBHJSD October 20th 2020, 3:10am |
 |
@stocknewstimes Myriad Genetics $MYGN Cut to Sell at BidaskClub https://t.co/Xjezz8QCL0 October 20th 2020, 3:10am |
 |
@tradersreport RT @Tickeron: $MYGN enters a Downtrend because Momentum Indicator dropped below the 0 level on October 14, 2020. View odds for this and oth… October 19th 2020, 9:10pm |
|
@Tickeron $MYGN enters a Downtrend because Momentum Indicator dropped below the 0 level on October 14, 2020. View odds for th… https://t.co/7xLfZyW2LB October 19th 2020, 9:10pm |
 |
@dispatchtribune Myriad Genetics $MYGN Cut to “Sell” at BidaskClub https://t.co/7ZJr3pwtvq October 19th 2020, 3:10am |
|
@Tickeron $MYGN enters a Downtrend as Momentum Indicator dropped below the 0 level on October 14, 2020. View odds for this an… https://t.co/C83GjVgnw2 October 18th 2020, 8:10pm |
 |
@ZolmaxNews BidaskClub Downgrades Myriad Genetics $MYGN to Sell https://t.co/DWgxn1RBUr October 18th 2020, 4:10am |
 |
@WatchlistN BidaskClub Downgrades Myriad Genetics $MYGN to Sell https://t.co/q6V0XYCtIA October 18th 2020, 4:10am |
|
@Tickeron $MYGN enters a Downtrend because Momentum Indicator dropped below the 0 level on October 14, 2020. View odds for th… https://t.co/cUw63yISpT October 17th 2020, 9:10pm |
 |
@HealthcareBeat Form DEF 14A (other definitive proxy statements) filed with the SEC $MYGN https://t.co/MH3Wmdg0GB October 17th 2020, 2:10pm |
|
@HealthcareBeat Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $MYGN https://t.co/Epgr2UeouM October 17th 2020, 1:10pm |
|
@Tickeron $MYGN enters a Downtrend because Momentum Indicator dropped below the 0 level on October 14, 2020. View odds for th… https://t.co/8Ow6DEN8R4 October 16th 2020, 10:10pm |
|
@TheMarketsDaily Myriad Genetics $MYGN Stock Price Down 7.6% https://t.co/AWCFW2qnre October 16th 2020, 10:10am |
 |
@FlashAlert_me $MYGN [15s. delayed]: Issued Press Release on October 16, 09:05:00: German Federal Joint Committee (G-BA) Issues Na… https://t.co/OHEECU1Fsj October 16th 2020, 9:10am |
 |
@stock_titan $MYGN German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict® Breast Cancer… https://t.co/6FRYLg8cbA October 16th 2020, 9:10am |
 |
@ThisLincolnian BidaskClub Lowers Myriad Genetics $MYGN to Sell https://t.co/5KHEFyjiXQ October 16th 2020, 1:10am |
 |
@TickerReport BidaskClub Lowers Myriad Genetics $MYGN to Sell https://t.co/e6CqCyHArV October 16th 2020, 1:10am |
 |
@dailypoliticaln BidaskClub Lowers Myriad Genetics $MYGN to Sell https://t.co/fxy32S0TX2 October 16th 2020, 1:10am |
|
@Tickeron $MYGN enters a Downtrend because Momentum Indicator dropped below the 0 level on October 14, 2020. View odds for th… https://t.co/tjAxMyLfqw October 15th 2020, 10:10pm |
 |
@WeekHerald Myriad Genetics, Inc. $MYGN Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/GO9NFgTOZh October 15th 2020, 9:10pm |
 |
@Rhizome333 $MYGN loaded what I could near or under the 12 handles this morning... so far so good... imo too cheap to ignore October 15th 2020, 2:10pm |
 |
@Briefingcom $MYGN: Myriad Genetics implements corporate governance changes in support of stakeholder interests https://t.co/OfWvrz4sBv October 15th 2020, 9:10am |
 |
@jodietheai $MYGN: Myriad Genetics announced today that the company has filed its fiscal year 2020 proxy statement . The compa… https://t.co/LzrFP1Y3wp October 15th 2020, 7:10am |
 |
@sbwcws Myriad files 2020 proxy statement, announces corporate governance changes $MYGN October 15th 2020, 7:10am |
 |
@otcdynamics $MYGN Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate Governance Changes In Support of… https://t.co/UNuAzYMUqI October 15th 2020, 7:10am |
|
@FlashAlert_me $MYGN [15s. delayed] filed form DEFA14A on October 15, 07:20:29 https://t.co/XkkC2GbdG8 October 15th 2020, 7:10am |
 |
@EdgarInsider FORM 8-K [Press/News Current Report] recently SEC filed. $MYGN MYRIAD GENETICS INC https://t.co/abJrVgnjE8 October 15th 2020, 7:10am |
|
@FlashAlert_me $MYGN [15s. delayed] filed form 8-K on October 15, 07:18:56: Item5.02: Departure of Election 0f Officers or Compens… https://t.co/GJmHcwa6ez October 15th 2020, 7:10am |
 |
@Allstocknews $MYGN New Form DEFA14A for Myriad Genetics, Inc. From our Stock News Alerts App October 15th 2020, 7:10am |
|
@Allstocknews $MYGN New Form DEF 14A for Myriad Genetics, Inc. From our Stock News Alerts App October 15th 2020, 7:10am |
 |
@fintel_io $MYGN / Myriad Genetics files form DEF 14A https://t.co/10uBQNeH4w October 15th 2020, 7:10am |
|
@HealthcareBeat Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $MYGN https://t.co/6yIqYiAIvI October 15th 2020, 7:10am |
|
@FlashAlert_me $MYGN [15s. delayed] filed form DEFA14A on October 15, 07:05:59 https://t.co/rNlWxwxqji October 15th 2020, 7:10am |
|
@FlashAlert_me $MYGN [15s. delayed] filed form DEF 14A on October 15, 07:03:34 https://t.co/ztfyWI24wk October 15th 2020, 7:10am |
|
@FlashAlert_me $MYGN [15s. delayed]: Issued Press Release on October 15, 07:05:00: Myriad Genetics Files Fiscal Year 2020 Proxy St… https://t.co/tpiD3NpLIh October 15th 2020, 7:10am |
|
@stock_titan $MYGN Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate Governance Changes In Support of… https://t.co/QJyJOErd3h October 15th 2020, 7:10am |
|
@tradersreport RT @Tickeron: $MYGN's 10-day Moving Average moved above its 50-day Moving Average on October 9, 2020. View odds for this and other indicato… October 14th 2020, 10:10pm |
|
@Tickeron $MYGN's 10-day Moving Average moved above its 50-day Moving Average on October 9, 2020. View odds for this and othe… https://t.co/t3R70QLDDJ October 14th 2020, 10:10pm |
 |
@bio_report $MYGN under a billion market cap again. So easy to make money down here trading weekly between $12-15 with very lit… https://t.co/8hRhAqsTPa October 14th 2020, 10:10am |
 |
@tq_equities $MYGN dominated by bears dragging the market lower throughout the day: https://t.co/2apunkmaj4 Sentiment: Bearish #MYGN #Myriad October 14th 2020, 7:10am |
|
@Tickeron $MYGN's 10-day Moving Average moved above its 50-day Moving Average on October 9, 2020. View odds for this and othe… https://t.co/30x1lLBwXJ October 13th 2020, 10:10pm |
|
@bio_report $MYGN whenever stock drops it’s on super low volume. Ridiculously cheap October 13th 2020, 1:10pm |
 |
@SwingTradeBot Recent $MYGN technical alerts: Stochastic Reached Overbought... https://t.co/1ayvR7H0Cj October 13th 2020, 9:10am |
 |
@InsiderAlerts4U $MYGN: New Insider Filing on MYRIAD GENETICS INC's President, MGL NICOLE LAMBERT: https://t.co/y16n5V8vYy October 13th 2020, 8:10am |
|
@InsiderAlerts4U $MYGN: New Insider Filing on MYRIAD GENETICS INC's Executive VP Human Resources JAYNE B. HART: https://t.co/LXEjXOhsIC October 13th 2020, 8:10am |
|
@InsiderAlerts4U $MYGN: New Insider Filing on MYRIAD GENETICS INC's E.V.P., General Counsel BENJAMIN JACKSON: https://t.co/rnItO3BnCJ October 13th 2020, 8:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
